Latest Breaking News On - Investigator global assessment treatment success - Page 1 : comparemela.com

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNeal walkerDouglas manionAclaris therapeutics incExchange commissionStatistically significant resultPrimary efficacy endpointSystemic exposure supportsWell toleratedAclari chairmanEczema areaSeverity indexInvestigator global assessment treatment successAclari chief executiveAclaris therapeuticsPrivate securities litigation reform act

Aclaris Therapeutics, Inc Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis

Aclaris Therapeutics, Inc. announced top-line results from its Phase 2b study of ATI-1777, an investigational topical ?soft? JAK 1/3 inhibitor, in patients with mild to severe atopic dermatitis ..

United statesAclaris therapeutics incAclaris therapeuticsEczema areaSeverity indexInvestigator global assessment treatment success

Aclaris Therapeutics Shares Fall On Mixed Results From Mid-Stage Eczema Trial - Aclaris Therapeutics (NASDAQ:ACRS)

Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to 

Aclaris therapeutics incTherapeutics incEczema areaSeverity indexInvestigator global assessment treatment success

Incyte shares positive results for Opzelura cream in children with atopic dermatitis

Incyte shares positive results for Opzelura cream in children with atopic dermatitis
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Jim leeEuropean commissionInvestigator global assessment treatment successEuropean medicines agencyMedicinal productsHuman use